Cognitive behavioural therapy and short-term psychoanalytical psychotherapy versus a brief psychosocial intervention in adolescents with unipolar major depressive disorder (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled superiority trial

The Lancet Psychiatry

Volumn 4, Issue 2, 2017, Pages 109-119

  Goodyer, Ian M ^a   Reynolds, Shirley ^b   Barrett, Barbara ^c   Byford, Sarah ^c   Dubicka, Bernadka ^d   Hill, Jonathan ^b   Holland, Fiona ^d   Kelvin, Raphael ^a   Midgley, Nick ^e   Roberts, Chris ^d   Senior, Rob ^f   Target, Mary ^g   Widmer, Barry ^a   Wilkinson, Paul ^a   Fonagy, Peter ^g  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF READING   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e ANNA FREUD CENTRE   (United Kingdom)

^f TAVISTOCK CLINIC   (United Kingdom)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; BREATHING DISORDER; CHILD; CLINICAL EFFECTIVENESS; COGNITIVE BEHAVIORAL THERAPY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DROWSINESS; DSM-IV; FATIGUE; FEMALE; FOLLOW UP; HUMAN; INTENTION TO TREAT ANALYSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; PSYCHOANALYTICAL PSYCHOTHERAPY; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; SELF REPORT; SINGLE BLIND PROCEDURE; SLEEP DISORDER; SOCIAL CARE; SWEATING; TREATMENT DURATION; CLINICAL TRIAL; COST BENEFIT ANALYSIS; ECONOMICS; ENGLAND; NATIONAL HEALTH SERVICE; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; STATISTICAL MODEL; TREATMENT OUTCOME;

ADOLESCENT; CHILD; COGNITIVE BEHAVIORAL THERAPY; COST-BENEFIT ANALYSIS; DEPRESSIVE DISORDER, MAJOR; ENGLAND; FEMALE; HUMANS; LINEAR MODELS; MALE; PSYCHIATRIC STATUS RATING SCALES; SELF REPORT; STATE MEDICINE; TREATMENT OUTCOME;

EID: 85007425409     PISSN: 22150366     EISSN: 22150374     Source Type: Journal    
DOI: 10.1016/S2215-0366(16)30378-9     Document Type: Article

References (32)

1. 1 Whiteford, HA, Degenhardt, L, Rehm, J, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 382 (2013), 1575–1586.
2. 2 Cox, GR1, Fisher, CA, De Silva, S, et al. Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents. Cochrane Database Syst Rev, 11, 2012 CD007504.
3. 3 March, J, Silva, S, Petrycki, S, et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA 292 (2004), 807–820.
4. 4 Rush, AJ, Wisniewski, SR, Zisook, S, et al. Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report. Psychol Med 42 (2012), 1131–1149.
5. 5 National Institute for Health and Care Excellence. CG28: depression in children and young people: identification and management in primary, community and secondary care, 2005, National Institute for Health and Care Excellence, London.
6. 6 Clarke, K, Mayo-Wilson, E, Kenny, J, et al. Can non-pharmacological interventions prevent relapse in adults who have recovered from depression? A systematic review and meta-analysis of randomised controlled trials. Clin Psychol Rev 39 (2015), 58–70.
7. 7 Connolly Gibbons, MB, Gallop, R, Thompson, D, et al. Comparative effectiveness of cognitive therapy and dynamic psychotherapy for major depressive disorder in a community mental health setting: a randomized clinical noninferiority trial. JAMA Psychiatry 73 (2016), 904–911.
8. 8 Abbass, A, Rabung, S, Leichsenring, F, et al. Psychodynamic psychotherapy for children and adolescents: a meta-analysis of short-term psychodynamic models. J Am Acad Child Adolesc Psychiatry 52 (2013), 863–875.
9. 9 Trowell, J, Joffe, I, Campbell, J, et al. Childhood depression: a place for psychotherapy. An outcome study comparing individual psychodynamic psychotherapy and family therapy. Eur Child Adolesc Psychiatry 16 (2007), 157–167.
10. 10 Weisz, JR, McCarty, CA, Valeri, SM, Effects of psychotherapy for depression in children and adolescents: a meta-analysis. Psychol Bull 132 (2008), 132–149.
11. 11 Goodyer, I, Dubicka, B, Wilkinson, P, et al. Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial. BMJ, 335, 2007, 142.
12. 12 American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 2000, American Psychiatry Association, Washington, DC.
13. 13 Goodyer, IM, Tsancheva, S, Byford, S, et al. Improving mood with psychoanalytic and cognitive therapies (IMPACT): a pragmatic effectiveness superiority trial to investigate whether specialised psychological treatment reduces the risk for relapse in adolescents with moderate to severe unipolar depression: study protocol for a randomised controlled trial. Trials, 12, 2011, 175.
14. 14 Graham, P, Reynolds, S, Cognitive behaviour therapy for children and families, 3rd edn., 2015, Cambridge University Press, Cambridge.
15. 15 Hilsenroth, MJ, Blagys, MD, Ackerman, SJ, Bonge, DR, Blais, MA, Measuring psychodynamic-interpersonal and cognitive-behavioral techniques: development of the comparative psychotherapy process scale. Psychotherapy: Theory, Research, Practice, Training 42 (2005), 340–356.
16. 16 Daviss, WB, Birmaher, B, Melhem, NA, Axelson, DA, Michaels, SM, Brent, DA, Criterion validity of the Mood and Feelings Questionnaire for depressive episodes in clinic and non-clinic subjects. J Child Psychol Psychiatry 47 (2006), 927–934.
17. 17 Gowers, SG, Harrington, RC, Whitton, A, et al. Health of the Nation Outcome Scales for Children and Adolescents (HoNOSCA). Glossary for HoNOSCA score sheet. Br J Psychiatry 174 (1999), 428–431.
18. 18 Bamber, D, Tamplin, A, Park, RJ, et al. Development of a short leyton obsessional inventory for children and adolescents. J Am Acad Child Adolesc Psychiatry 41 (2002), 1246–1252.
19. 19 Reynolds, CR, Richmond, BO, What I think and feel: a revised measure of children's manifest anxiety. J Abnorm Child Psychol 25 (1997), 15–20.
20. 20 Kaufman, J, Birmaher, B, Brent, D, et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36 (1997), 980–988.
21. 21 Posner, K, Brown, GK, Stanley, B, et al. The Columbia–Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry 168 (2011), 1266–1277.
22. 22 Vrouva, I, Fonagy, P, Fearon, PR, Roussow, T, The risk-taking and self-harm inventory for adolescents: development and psychometric evaluation. Psychol Assess 22 (2010), 852–865.
23. 23 Byford, S, Barrett, B, Roberts, C, et al. Cost-effectiveness of selective serotonin reuptake inhibitors and routine specialist care with and without cognitive behavioural therapy in adolescents with major depression. Br J Psychiatry 191 (2007), 521–527.
24. 24 Byford, S, The validity and responsiveness of the EQ-5D measure of health-related quality of life in an adolescent population with persistent major depression. J Ment Health 22 (2013), 101–110.
25. 25 Walwyn, R, Roberts, C, Therapist variation within randomised trials of psychotherapy: implications for precision, internal and external validity. Stat Methods Med Res 19 (2010), 291–315.
26. 26 Byford, S, Barrett, B, Roberts, C, et al. Cost-effectiveness of selective serotonin reuptake inhibitors and routine specialist care with and without cognitive behavioural therapy in adolescents with major depression. Br J Psychiatry 191 (2007), 521–527.
27. 27 National Institute for Health and Care Excellence (NICE). Guide to the methods of technology appraisal, 2013, NICE, London.
28. 28 Fenwick, E, Claxton, K, Sculpher, M, Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 10 (2001), 779–787.
29. 29 Vitiello, B1, Emslie, G, Clarke, G, et al. Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample. J Clin Psychiatry 72 (2011), 388–396.
30. 30 Birmaher, B, Brent, DA, Kolko, D, et al. Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder. Arch Gen Psychiatry 57 (2000), 29–36.
31. 31 Curry, J, Silva, S, Rohde, P, et al. Recovery and recurrence following treatment for adolescent major depression. Arch Gen Psychiatry 68 (2011), 263–269.
32. 32 Brent, DA, Brunwasser, SM, Hollon, SD, et al. Effect of a cognitive-behavioral prevention program on depression 6 years after implementation among at-risk adolescents: a randomized clinical trial. JAMA Psychiatry 72 (2016), 1110–1118.